The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ex vivo oncolytic and immune activity of CF33-hNIS-antiPDL1 against fresh peritoneal cells from patients with gastric cancer with and without peritoneal metastases.
 
Zhifang Zhang
No Relationships to Disclose
 
Annie Yang
No Relationships to Disclose
 
Shyambabu Chaurasiya
No Relationships to Disclose
 
Anthony K Park
Consulting or Advisory Role - Imugene
Research Funding - Imugene
Patents, Royalties, Other Intellectual Property - Oncolytic virus licensed to Imugene Limited
Travel, Accommodations, Expenses - Imugene
 
Sang-In Kim
No Relationships to Disclose
 
Jianming Lu
No Relationships to Disclose
 
Hannah Valencia
No Relationships to Disclose
 
Yuman Fong
Stock and Other Ownership Interests - Imugene; Pfizer (I)
Consulting or Advisory Role - Imugene; Johnson & Johnson; Medtronic; Perfint Healthcare; Sangamo Bioscience; Vergent Bioscience
Patents, Royalties, Other Intellectual Property - Viral Vector licensed to Imugene; Viral vector licensed to Merck
 
Yanghee Woo
Consulting or Advisory Role - Imugene; Johnson and Johnson (Ethicon)
Travel, Accommodations, Expenses - Imugene